Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies
Autor: | Raquel Jover-Díaz, Luis Gorospe, Agustina Vicente-Bártulos |
---|---|
Rok vydání: | 2012 |
Předmět: |
medicine.medical_specialty
Genital Neoplasms Female Urology Uterine Cervical Neoplasms Multimodal Imaging Patient Positioning Clinical Protocols Fluorodeoxyglucose F18 Internal medicine Gynecologic cancer Medicine Humans Radiology Nuclear Medicine and imaging In patient Pelvis Fluorodeoxyglucose PET-CT Radiological and Ultrasound Technology business.industry Gastroenterology General Medicine Hepatology medicine.disease Patient management Pulmonary embolism medicine.anatomical_structure Positron-Emission Tomography Carcinoma Squamous Cell Female Radiology Radiopharmaceuticals business Pulmonary Embolism Tomography X-Ray Computed medicine.drug |
Zdroj: | Abdominal imaging. 37(6) |
ISSN: | 1432-0509 |
Popis: | Integrated positron emission tomography–computed tomography (PET–CT) represents a major technologic advance in oncologic imaging of patients with gynecologic malignancies, since it improves localization of regions of increased 18F-fluorodeoxyglucose (FDG) uptake and staging/restaging accuracy by allowing a near-simultaneous acquisition of co-registered, spatially matched metabolic and anatomic data in the same examination. However, physiologic processes, normal variants, and many benign lesions within the pelvis can accumulate FDG and may be confused with malignant neoplasms. Conversely, false-negative results due to malignancies with low FDG uptake can pose a diagnostic challenge in patients with gynecologic cancer. With the increased use of PET–CT in patients with gynecologic malignancies, misinterpretation of these potential pitfalls can have significant implications and alter staging/restaging and patient management. In this article, we review these potential pitfalls in integrated PET–CT of the pelvis in patients with gynecologic cancer. |
Databáze: | OpenAIRE |
Externí odkaz: |